Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer
- Author
- JAE YEN SONG1 ; HYUN HEE JO1 ; MEE RAN KIM1 ; YOUNG OAK LEW1 ; KI SUNG RYU1 ; JUNG HO CHA2 ; CHANG SUK KANG3 ; DONAHOE, Patricia K4 ; MACLAUGHLIN, David T4 ; JANG HEUB KIM1
[1] Department of Obstetrics and Gynecology, The Catholic University of Korea, Seoul, Korea, Republic of
[2] Department of Anatomy and, The Catholic University of Korea, Seoul, Korea, Republic of
[3] Department of Clinical Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of
[4] Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States - Source
International journal of oncology. 2012, Vol 40, Num 6, pp 2013-2021, 9 p ; ref : 40 ref
- ISSN
- 1019-6439
- Scientific domain
- Medical oncology
- Publisher
- Editorial Academy of the International Journal of Oncology, Athens
- Publication country
- Greece
- Document type
- Article
- Language
- English
- Author keyword
- Müllerian inhibiting substance type II receptor Müllerian inhibiting substance anti-Müllerian hormone cervical cancer immunohistochemistry in situ hybridization
- Keyword (fr)
- Anticancéreux Cancer du col de l'utérus Cancérologie Homme Hormone antimüllérienne Immunohistochimie Récepteur biologique Hybridation in situ Anatomopathologie Cancer Pathologie de l'appareil génital femelle Pathologie du col de l'utérus Tumeur maligne
- Keyword (en)
- Antineoplastic agent Cervical cancer Cancerology Human Antimüllerian hormone Immunohistochemistry Biological receptor In situ hybridization Anatomic pathology Cancer Female genital diseases Uterine cervix diseases Malignant tumor
- Keyword (es)
- Anticanceroso Cáncer de cuello del útero Cancerología Hombre Hormona antimulleriana Inmunohistoquímica Receptor biológico Hibridación in situ Anatomía patológica Cáncer Aparato genital hembra patología Cuello útero patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20C Female genital diseases / 002B20C02 Tumors
- Discipline
- Gynecology. Andrology. Obstetrics Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 25814974
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:124:\"Expression of M\u00fcllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer\";s:9:\"\u0000*\u0000jtitle\";s:33:\"International journal of oncology\";s:9:\"\u0000*\u0000stitle\";s:13:\"Int. j. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"2013\";s:8:\"\u0000*\u0000epage\";s:4:\"2021\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1019-6439\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"JAE YEN SONG\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:11:\"HYUN HEE JO\";i:1;s:11:\"MEE RAN KIM\";i:2;s:13:\"YOUNG OAK LEW\";i:3;s:11:\"KI SUNG RYU\";i:4;s:11:\"JUNG HO CHA\";i:5;s:14:\"CHANG SUK KANG\";i:6;s:19:\"DONAHOE, Patricia K\";i:7;s:20:\"MACLAUGHLIN, David T\";i:8;s:13:\"JANG HEUB KIM\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:124:\"Expression of M\u00fcllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer\";s:8:\"\u0000*\u0000place\";s:6:\"Athens\";s:6:\"\u0000*\u0000pub\";s:58:\"Editorial Academy of the International Journal of Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:124:\"Expression of M\u00fcllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer\";s:9:\"\u0000*\u0000jtitle\";s:33:\"International journal of oncology\";s:9:\"\u0000*\u0000stitle\";s:13:\"Int. j. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"2013\";s:8:\"\u0000*\u0000epage\";s:4:\"2021\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1019-6439\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"JAE YEN SONG\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:11:\"HYUN HEE JO\";i:1;s:11:\"MEE RAN KIM\";i:2;s:13:\"YOUNG OAK LEW\";i:3;s:11:\"KI SUNG RYU\";i:4;s:11:\"JUNG HO CHA\";i:5;s:14:\"CHANG SUK KANG\";i:6;s:19:\"DONAHOE, Patricia K\";i:7;s:20:\"MACLAUGHLIN, David T\";i:8;s:13:\"JANG HEUB KIM\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:124:\"Expression of M\u00fcllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer\";s:8:\"\u0000*\u0000place\";s:6:\"Athens\";s:6:\"\u0000*\u0000pub\";s:58:\"Editorial Academy of the International Journal of Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:124:\"Expression of M\u00fcllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer\";s:9:\"\u0000*\u0000jtitle\";s:33:\"International journal of oncology\";s:9:\"\u0000*\u0000stitle\";s:13:\"Int. j. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"2013\";s:8:\"\u0000*\u0000epage\";s:4:\"2021\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1019-6439\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"JAE YEN SONG\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:11:\"HYUN HEE JO\";i:1;s:11:\"MEE RAN KIM\";i:2;s:13:\"YOUNG OAK LEW\";i:3;s:11:\"KI SUNG RYU\";i:4;s:11:\"JUNG HO CHA\";i:5;s:14:\"CHANG SUK KANG\";i:6;s:19:\"DONAHOE, Patricia K\";i:7;s:20:\"MACLAUGHLIN, David T\";i:8;s:13:\"JANG HEUB KIM\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:124:\"Expression of M\u00fcllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer\";s:8:\"\u0000*\u0000place\";s:6:\"Athens\";s:6:\"\u0000*\u0000pub\";s:58:\"Editorial Academy of the International Journal of Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:124:\"Expression of M\u00fcllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer\";s:9:\"\u0000*\u0000jtitle\";s:33:\"International journal of oncology\";s:9:\"\u0000*\u0000stitle\";s:13:\"Int. j. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"2013\";s:8:\"\u0000*\u0000epage\";s:4:\"2021\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1019-6439\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"JAE YEN SONG\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:11:\"HYUN HEE JO\";i:1;s:11:\"MEE RAN KIM\";i:2;s:13:\"YOUNG OAK LEW\";i:3;s:11:\"KI SUNG RYU\";i:4;s:11:\"JUNG HO CHA\";i:5;s:14:\"CHANG SUK KANG\";i:6;s:19:\"DONAHOE, Patricia K\";i:7;s:20:\"MACLAUGHLIN, David T\";i:8;s:13:\"JANG HEUB KIM\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:124:\"Expression of M\u00fcllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer\";s:8:\"\u0000*\u0000place\";s:6:\"Athens\";s:6:\"\u0000*\u0000pub\";s:58:\"Editorial Academy of the International Journal of Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:124:\"Expression of M\u00fcllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer\";s:9:\"\u0000*\u0000jtitle\";s:33:\"International journal of oncology\";s:9:\"\u0000*\u0000stitle\";s:13:\"Int. j. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"2013\";s:8:\"\u0000*\u0000epage\";s:4:\"2021\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1019-6439\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"JAE YEN SONG\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:11:\"HYUN HEE JO\";i:1;s:11:\"MEE RAN KIM\";i:2;s:13:\"YOUNG OAK LEW\";i:3;s:11:\"KI SUNG RYU\";i:4;s:11:\"JUNG HO CHA\";i:5;s:14:\"CHANG SUK KANG\";i:6;s:19:\"DONAHOE, Patricia K\";i:7;s:20:\"MACLAUGHLIN, David T\";i:8;s:13:\"JANG HEUB KIM\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:124:\"Expression of M\u00fcllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer\";s:8:\"\u0000*\u0000place\";s:6:\"Athens\";s:6:\"\u0000*\u0000pub\";s:58:\"Editorial Academy of the International Journal of Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
